Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPittenger & Anderson Inc
Latest Disclosed Ownership11 shares
Latest Disclosed Value $ 1,534
Pittenger & Anderson Inc ownership in GILD / Gilead Sciences, Inc.

On May 1, 2026 - Pittenger & Anderson Inc filed a 13F-HR form disclosing ownership of 11 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,534 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 11 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F GILEAD SCIENCES COM 375558103 11 0 0.00 2 0.00 0.0001
2026-02-02 2025-12-31 13F GILEAD SCIENCES COM 375558103 11 0 0.00 1 0.00 0.0001
2025-11-03 2025-09-30 13F GILEAD SCIENCES COM 375558103 11 11 1 0.0000
2025-07-30 2025-06-30 13F GILEAD SCIENCES COM 375558103 0 -579 -100.00 0 -100.00
2025-05-01 2025-03-31 13F GILEAD SCIENCES COM 375558103 579 579 65 0.0024
2024-05-02 2024-03-31 13F GILEAD SCIENCES COM 375558103 0 -450 -100.00 0 -100.00
2024-02-02 2023-12-31 13F GILEAD SCIENCES COM 375558103 450 0 0.00 36 9.09 0.0016
2023-11-02 2023-09-30 13F GILEAD SCIENCES COM 375558103 450 0 0.00 34 -2.94 0.0017
2023-08-09 2023-06-30 13F GILEAD SCIENCES COM 375558103 450 450 35 0.0017
2022-07-14 2022-06-30 13F GILEAD SCIENCES COM 375558103 0 -26 -100.00 0 -100.00
2022-04-28 2022-03-31 13F GILEAD SCIENCES COM 375558103 26 26 2 0.0001
2019-05-10 2019-03-31 13F GILEAD SCIENCES COM 375558103 0 -1,130 -100.00 0 -100.00
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 1,130 0 0.00 71 -18.39 0.0065
2018-10-12 2018-09-30 13F GILEAD SCIENCES COM 375558103 1,130 800 242.42 87 278.26 0.0069
2018-08-15 2018-06-30 13F GILEAD SCIENCES COM 375558103 330 -170 -34.00 23 -39.47 0.0020
2018-05-08 2018-03-31 13F GILEAD SCIENCES COM 375558103 500 70 16.28 38 22.58 0.0033
2018-02-13 2017-12-31 13F GILEAD SCIENCES COM 375558103 430 200 86.96 31 63.16 0.0027
2017-11-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 230 105 84.00 19 111.11 0.0017
2017-08-10 2017-06-30 13F GILEAD SCIENCES COM 375558103 125 35 38.89 9 50.00 0.0009
2017-05-15 2017-03-31 13F GILEAD SCIENCES COM 375558103 90 -4,275 -97.94 6 -98.08 0.0006
2017-02-16 2016-12-31 13F GILEAD SCIENCES COM 375558103 4,365 -925 -17.49 313 -25.30 0.0333
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 5,290 -8,913 -62.75 419 -64.64 0.0465
2016-08-09 2016-06-30 13F GILEAD SCIENCES COM 375558103 14,203 -48,195 -77.24 1,185 -79.33 0.1307
2016-05-13 2016-03-31 13F GILEAD SCIENCES COM 375558103 62,398 17,145 37.89 5,732 25.18 0.6666
2016-02-10 2015-12-31 13F GILEAD SCIENCES COM 375558103 45,253 1,823 4.20 4,579 7.39 0.5735
2015-11-10 2015-09-30 13F GILEAD SCIENCES COM 375558103 43,430 4,960 12.89 4,264 -5.33 0.5635
2015-08-14 2015-06-30 13F GILEAD SCIENCES COM 375558103 38,470 7,785 25.37 4,504 49.58 0.5780
2015-05-12 2015-03-31 13F GILEAD SCIENCES COM 375558103 30,685 12,645 70.09 3,011 77.12 0.3878
2015-02-18 2014-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 18,040 16,870 1,441.88 1,700 1,260.00 0.2241
2015-02-13 2014-12-31 13F GILEAD SCIENCES COM 375558103 18,040 1,700
2014-11-13 2014-09-30 13F Gilead Sciences COM 375558103 1,170 110 10.38 125 42.05 0.0183
2014-08-15 2014-06-30 13F GILEAD SCIENCES COM 375558103 1,060 1,060 -89.76 88 -83.43 0.0130
2013-11-12 2013-09-30 13F GILEAD SCIENCES COM 375558103 0 -10,350 -100.00 0 -100.00
2013-08-08 2013-06-30 13F GILEAD SCIENCES COM 375558103 10,350 10,350 531 0.0917
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.